Pinnacle Treatment Centers OH XII LLC is a licensed substance use treatment provider in Sandusky, OH, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. On site detox services are available, so withdrawal can be managed before treatment begins. Methadone is available as part of medication assisted treatment for opioid use disorder. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentDetoxification
Medications
Methadone used in TreatmentBuprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Opioids detoxificationMedication routinely used during detoxification
Payment accepted
MedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentCommission on Accreditation of Rehabilitation Facilities (CARF)Federally Qualified Health CenterSAMHSA certification for opioid treatment program (OTP)Drug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare